3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
13
Triple Negative Breast Neoplasms
5
Neoplasm Metastasis
3
Urinary Bladder Neoplasms
2
Urethral Neoplasms
1
Ureteral Neoplasms
1
Sarcoma
1
Refractory Solid Tumors
1
Liposarcoma
1
HR+HER2- Breast Cancer
1
Carcinoma, Transitional Cell
1
Interventions
Specimen Handling
3
Taxes
2
Carboplatin
2
pegfilgrastim
1
olaparib
1
X-Rays
1
Therapeutics
1
Radiotherapy
1
Radiation
1
Panitumumab
1
Palliative Care
1
Paclitaxel
1
Methods
1
Magnetic Resonance Spectroscopy
1
Magnetic Resonance Imaging
1
Interviews as Topic
1
Indocyanine Green
1
Exercise Test
1
Epirubicin
1
Educational Status
1
Early Intervention, Educational
1
Docetaxel
1
Clostridium perfringens epsilon-toxin
1
Albumin-Bound Paclitaxel
1
Accelerometry
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Inflammatory Breast Neoplasms
×
eribulin
×
90 days
×
Clear all
No trials found.